Total planned funding: $215,872,473
Allocations
Countries/Regions
Ukraine | $215,872,473 |
Organizational Types
Unknown | $62,838,882 |
NGO | $54,062,564 |
Private Contractor | $32,379,701 |
Own Agency | $27,549,455 |
Multi-lateral Agency | $12,938,586 |
University | $11,856,234 |
Implementing Agency | $6,825,040 |
Other USG Agency | $5,572,011 |
Host Country Government Agency | $1,850,000 |
Program Areas
Governance and Systems | $89,058,484 |
Treatment | $37,637,754 |
Testing | $33,621,630 |
Prevention | $22,431,279 |
Management and Operations | $19,370,767 |
Care | $13,752,559 |
Budget Codes
OHSS: Health Systems Strengthening | $52,036,838 |
HVCT: Testing: HIV Testing and Counseling | $33,621,630 |
HTXS: Treatment: Adult Treatment | $25,073,759 |
HVSI: Strategic Information | $21,795,279 |
HVMS: Management and Operations | $19,370,767 |
HLAB: Laboratory Infrastructure | $15,226,367 |
HTXD: Treatment: ARV Drugs | $12,563,995 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $12,100,031 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,155,113 |
HVTB: Care: TB/HIV | $7,043,485 |
HBHC: Care: Adult Care and Support | $4,171,249 |
HMBL: Biomedical Prevention: Blood Safety | $2,855,941 |
HKID: Care: Orphans and Vulnerable Children | $2,537,825 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $70,194 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
PDTX: Treatment: Pediatric Treatment | $0 |
Top Partner Programs
Not Available:
$46,914,023
Countries/Regions
Chemonics International:
$19,792,383
Countries/Regions
USG Aggregated Agencies:
$19,262,069
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions